RxDoctor Payments Data

Brian Durie

Hematology & Oncology · West Hollywood, CANPI 1649369414

Payments from drug & device makers

$804,481in general payments, 2019–2025

Across 17 payments — averaging $47,322 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$427K
  • Pfizer$250K
  • Janssen Research & Development, LLC$125K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • E.r. Squibb & Sons, L.L.C.$497
  • BD$88
$24,062in research payments, 2019–2025

Across 9 payments — averaging $2673.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$10K
  • Regeneron$7K
  • Amgen$6K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K

What the payments were for

  • Consulting fees$1,98054%
  • Food & beverage$2697%
  • Education$1,44739%

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$804,481 in reported general payments places this provider in the 85th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in West Hollywood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →